Human T-Lymphotropic Virus, Associated Myelopathy and Leukemia: A Review
DOI:
https://doi.org/10.47430/ujmr.1832.011Keywords:
CD4 cells, leukaemia, lymphoma, myelopathy, oncogenic viruses, paraparesis, retroviruses, zoonosisAbstract
Human T Lymphotronic Virus type 1 was the first retrovirus discovered associated with fatal diseases in humans and said to have emerged following zoonotic transmission from simian populations. Their primary target is adult CD4 T-cells and most infected individuals are asymptomatic. However, a significant number may develop persistent infection and progress to an aggressive lymphoproliferative disease, known as Adult T-cell Leukemia/Lymphoma-ATLL. Some may develop a debilitating neuro-inflammatory disease called Tropical Spastic Paraparesis-TSP, predominantly involving the lower limbs, with or without hyperactive urinary bladder. Unprotected sexual intercourse and breastfeeding account for the highest number of cases and is also transmitted by uncheck blood transfusion or sharing of contaminated sharps. ATLL and TSP are life-threatening diseases initially restricted to Middle East and some parts of Africa, but recently, cases are being reported in many parts of the world. Unfortunately, even though the antiretroviral therapy have greatly improved and significantly reduced HIV progression to AIDS, such great break through is not worthy benefit for HTLV infected individuals. Thus, they are identified as severe human diseases of public health concern. This review is an overview and contains update about the biology of the virus, its interaction with the host, HAM/TSP and ATLL; their epidemiology and clinical presentations.
Downloads
References
Achiron, A., Pinhas-Hamiel, O., Doll, L., Djaldetti, R., Chen, A., Ziv, I., Avni, A., Frankel, G., Melamed, E. and Shohat, B. (1993). Spastic paraparesis associated with human T-lymphotropic virus type I: a clinical, serological, and genomic study in Iranian-born Mashhad Jews. Annals of Neurology, 34 (5):670- 675.
https://doi.org/10.1002/ana.410340508
Akbarin, M. M., Rahimi, H., HassanNia, T., Razavi, G. S., Sabet, F. and Shirdel, A. (2013). Comparison of HTLV-I proviral load in Adult T cell leukemia/lymphoma (ATL), HTLV-I-associated myelopathy (HAM-TSP) and healthy carriers. Iranian Journal of Basic Medical Sciences, 16 (3):208-212.
Carles, G., Tortevoye, P., Tuppin, P., Ureta- Vidal, A., Peneau, C., El Guindi, W. and Gessain, A. (2004). HTLV-I infection and pregnancy. Journal Gynecology Obstetrics Biology and Reproduction, (Paris) 33:14-20.
https://doi.org/10.1016/S0368-2315(04)96307-7
Clark, J., Saxinger, C., Gibbs, W. N., Lofters, W., Lagranade, L., Deceulaer, K., Ensroth, A., Robert-Guroff, M., Gallo, R. C. and Blattner, W. A. (1985). Seroepidemiologic studies of human T-cell leukemia/lymphoma virus type I in Jamaica. International Journal of Cancer, 36 (1):37-41.
https://doi.org/10.1002/ijc.2910360107
Fuji, M. and Matsuoka, M. (2013). Human T-cell leukemia virus types 1 and 2. In: Knipe DM, Hawley PM, eds. Fields Virology. New York, Wolters Kluwer, Lippincott, Williams and Wilkins; pp 1474-501.
Futsch, N., Mahieux, R. and Dutartre, H. (2018). HTLV-1: The other pathogenic yet neglected human retrovirus: From transmission to therapeutic treatment. Viruses, 10:1.
https://doi.org/10.3390/v10010001
Gessain, A. and Cassar, O. (2012). Epidemiological aspects and world distribution of HTLV-1 infection. Frontiers in Microbiology, 3:1e23.
https://doi.org/10.3389/fmicb.2012.00388
Gonçalves, D. U., Proietti, F. A., Ribas, J. G., Araújo, M. G., Pinheiro, S. R., Guedes, A. C. and Carneiro-Proietti, A. B. (2010). Epidemiology, Treatment, and Prevention of Human T-cell leukemia virus type 1-associated diseases. Clinical Microbiology Review, 23:577-589.
https://doi.org/10.1128/CMR.00063-09
Hedayati-Moghaddam, M., Tehranian, F. and Bayati, M. (2015). Human T- Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors. Viruses, 7(11):5736-5745.
https://doi.org/10.3390/v7112904
Jamilii, P., Maghsudlu, M. and Safabakhsh, H. (2015). Seroepidemiology of Human T- Cell lymphotropic virus type-1 in blood donors of north-eastern Iran, Sabzevar. Asian Journal of Transfusion Science, 9:203-206.
https://doi.org/10.4103/0973-6247.154255
Karimi, G., Zadsar, M. and Pourfathollah, A. A. (2017). Seroprevalence and geographical distribution of human T- lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran. Virology Journal, 14:14.
https://doi.org/10.1186/s12985-017-0693-9
Kubota, R. (2017). Pathogenesis of human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis. Clinical Experimental Neuroimmunology, 8(2):117-128.
https://doi.org/10.1111/cen3.12395
Mahzounieh M., Ghorani M., Karimi A., Pourgheysari, B. and Nikoozad, R. (2015). Prevalence of Human T- Lymphotropic Virus Types I and II in Patients with Hematological Disorders in Isfahan, Iran. Jundishapur Journal Microbiology, 8:e17201.
https://doi.org/10.5812/jjm.8(5)2015.17201
Manel, N., Kim, F. J., Kinet, S., Taylor, N., Sitbon, M. and Battini, J. L. (2003). The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell, 115(4):449-459.
https://doi.org/10.1016/S0092-8674(03)00881-X
Murphy, E. L. (2016). Infection with human T- lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety. Transfusion in Clinical Biology, 23:13-19.
https://doi.org/10.1016/j.tracli.2015.12.001
Murphy, E. L. and Bruhn, R. L. (2015). Human T- lymphotropic virus (HTLV). In: Bennett JE, Dolin R, Blaser MJ, eds. Mendell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, Elsevier; pp 2038-53.
https://doi.org/10.1016/B978-1-4557-4801-3.00170-3
Murphy, E. L. and Bruhn, R. L. (2018). Human T- Lymphotropic Virus. https://oncohemakey.com/human-t- lymphotropic-virus-htlv/. 2018 [Accessed 4 March 2018].
Orland, J. R., Engstrom, J., Fridey, J., Sacher, R. A., Smith, J. W., Nass, C., Garratty, G., Newman, B., Smith, D., Wang, B., Loughlin, K. and Murphy, E. L. (2003). Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology, 61:1588-1594.
https://doi.org/10.1212/01.WNL.0000096011.92542.DA
Otani, M., Honda, N., Xia, P. C., Eguchi, K., Ichikawa, T., Watanabe, T., Yamaguchi, K., Nakao, K. and Yamamoto, T. (2012)."Distribution of Two Subgroups of Human T-Lymphotropic Virus Type 1 (HTLV-1) in Endemic Japan". Tropical Medicine and Health, 40(2):55-58.
https://doi.org/10.2149/tmh.2012-02
Qayyum, S. and Choi, J. K. (2014). Adult T-Cell Leukemia/Lymphoma. Achieve of Pathology and Laboratory Medicine, 138:282-286.
https://doi.org/10.5858/arpa.2012-0379-RS
Romanelli L. C., Caramelli P., Martins M. L., Gonçalves, D. U., Proietti, F. A., Ribas, J. G., Araújo, M. G. and Carneiro- Proietti, A. B. (2013). Incidence of human T cell lymphotropic virus type 1- associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil. AIDS Research in Human Retroviruses, 29:1199-202.
https://doi.org/10.1089/aid.2013.0086
Safabakksh, H., Jalalian, M. and Karimi, G. (2014). Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad. Global Health and Science, 6:99-104.
https://doi.org/10.5539/gjhs.v6n5p99
Santos, R. F. S., Conceição, G. C., Martins, M. S., Kraychete, A., Penalva, M. A., Carvalho, E. M., Lopes, A. A. and Rocha, P. N. (2017). Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients. BMC Nephrology, 18:64.
https://doi.org/10.1186/s12882-017-0484-y
Scadden, D. T., Freedman, A. R. and Robertson, P. (2018) Human T-lymphotropic virus type I: Virology, pathogenesis, and epidemiology. https://www.uptodate.com/contents/hu man-t-lymphotropic-virus-type-i-virology- pathogenesis-and-epidemiology. [Accessed 16 May 2018].
Schutte, C., Townsend, T., Van Coller, R. and Olorunju, S. (2012). Comparison of HTLV- associated myelopathy (HAM) in HIV- positive and HIV-negative patients at a tertiary South African hospital. South Africa Medical Journal, 103:43-46.
https://doi.org/10.7196/SAMJ.5298
Tabei, S. Z. (2011). Human T lypmphotrophic virus (HTLV1) related diseases. Iran Red Crescent Medical Journal, 13:374-376.
Takatsuki, K., Yamaguchi, K. and Matsouka, M. (1994). ATL and HTLV-1 related diseases. In: Takatsuki K, ed. Adult-Cell leukemia. New York: Oxford University Press; 1994. pp1-27.
Tanajura, D., Castro, N., Oliveira, P., Neto, A., Muniz, A., Carvalho, N. B., Orge, G., Santos, S. and Glesby, M. J. Carvalho
E. M. (2015). Neurological manifestations in human T-cell lymphotropic virus type 1 (HTLV-1)-infected individuals without HTLV-1-associated myelopathy/tropical spastic paraparesis: A longitudinal cohort study. Clinical Infectious Diseases, 2015;61:49-56.
https://doi.org/10.1093/cid/civ229
Tsukasaki, K. and Tobinai, K. (2014). Human T- cell Lymphotropic Virus Type I-Associated Adult T-cell Leukemia-Lymphoma: New Directions in Clinical Research. Clinical Cancer Research, 20:5217-5225.
https://doi.org/10.1158/1078-0432.CCR-14-0572
Utsunomiya, A., Choi, I., Chihara, D. and Seto, M. (2015). Recent advances in the treatment of adult T-cell leukemia-lymphomas. Cancer Science, 2015;344-51.
https://doi.org/10.1111/cas.12617
Vallinoto, A. C. R., Santana, B. B., Sá, K. S. G., Ferreira, T. C. S., Sousa, R. C. M., Azevedo, V. N., Feitosa, R. N. M., Machado, L. F. A., Ishak, M. O. G. and Ishak, R. (2015). HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene. Mediators in Inflammation, 1-7.
https://doi.org/10.1155/2015/804167
Verdonck K, González E, Van Dooren S. Vandamme, A. M., Vanham, G. and Gotuzzo, E. (2007). Human T- lymphotropic virus 1: Recent knowledge about an ancient infection. Lancet Infectious Disease, 7:266-281.
https://doi.org/10.1016/S1473-3099(07)70081-6
Willems L, Hasegawa H, Accolla R. Bangham, C., Bazarbachi, A., Bertazzoni,U., Carneiro- Proietti, A. B. de-F., Cheng, H., Chieco- Bianchi,L., Ciminale,V., Coelho-dos-Reis, J., Esparza,J., Gallo,R. C., Gessain, A., Gotuzzo, E., Hall, W., Harford, J., Hermine,O., Jacobson,S., Macchi,B., Macpherson, C., Mahieux, R., Matsuoka,M., Murphy, E., Peloponese,J- M., Simon,V., Tagaya, Y., Taylor,G. P., Watanabe, T. and Yamano, Y. (2017). Reducing the global burden of HTLV-1 infection: An agenda for research and action. Antiviral Research, 137:41e48.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 UMYU Journal of Microbiology Research (UJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
